Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humana (NY: HUM )

298.11 +2.40 (+0.81%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
37 38 Next >
Morgan Stanley Upgrades Humana: Here's What You Need To Know
Morgan Stanley upgraded its rating of Humana (NYSE:HUM) to Overweight with a price target of $549.00, changing its price target from $494.00 to $549.00. Shares of Humana are trading up 0.97% over the... 
Via Benzinga
Shares of Humana Inc. (HUM) Rise Above Previous 52-Week High
Via Investor Brand Network
Humana Inc. (NYSE: HUM) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Why This Bullish Humana Analyst Just Raised His Price Target To $549 On The Stock
Checks suggest Humana Inc (NYSE: HUM) has improved its competitive positioning, which could lead to stronger membership growth in 2023, according to Morgan Stanley. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
Upgrades 
Via Benzinga
8 Analysts Have This to Say About Humana
Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Humana Bumps Up FY22 Profit Outlook, Stops Factoring COVID-19 Impact In Guidance, Shares Jump
Via Benzinga
Keybanc Slashes PT On This Stock By 50%, Plus This Analyst Predicts $100 For PayPal
Susquehanna lowered the price target for PayPal Holdings, Inc. (NASDAQ: PYPL) from $115 to $100. PayPal shares fell 2.4% to $92.73 in pre-market trading. 
Via Benzinga
Oppenheimer Maintains Outperform Rating for Humana: Here's What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Humana (NYSE:HUM) and raise its price target from $520.00 to $550.00. Shares of Humana are trading down 0.25% over the last 24 hours, at... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
This Is What Whales Are Betting On Humana
Someone with a lot of money to spend has taken a bearish stance on Humana (NYSE:HUM). And retail traders should know. We noticed this today when the big position showed up on publicly available options... 
Via Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Gainers 
Via Benzinga
AFRM Stock Alert: What to Know as Regulatory Agency Targets Buy Now, Pay Later Companies
Affirm (AFRM) stock is a hot topic among traders on Thursday following news that CFPB plans to target "buy-now, pay-later" companies. 
Via InvestorPlace
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome... 
Via Benzinga
Netflix, Humana And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Nasdaq dropping around 70 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Railroads Rally As Looming Labor Deal May Divert Disaster
(Thursday Market Open) Equity index futures were slightly lower ahead of the market open as investors sorted through a slew of economic data. 
Via Benzinga
Humana (HUM) Stock Pops on Revised Guidance
Humana (HUM) stock is heading higher on Thursday after the health insurance company revised its guidance during its Investor Day event. 
Via InvestorPlace
Humana Introduces Mid-Term Adjusted EPS Target of $37 in 2025 and Raises Full Year 2022 Adjusted EPS Financial Guidance to ‘approximately $25’ at Investor Day
From Humana Inc.
Via Business Wire
Humana Elects Brad D. Smith to Board of Directors
From Humana Inc.
Via Business Wire
Humana to Host Virtual Investor Update on September 15, 2022
From Humana Inc.
Via Business Wire
AM Best Affirms Credit Ratings of Humana Inc. and Its Health Insurance Subsidiaries
From AM Best
Via Business Wire
Humana Finalizes Launch of CenterWell Home Health
From Humana Inc.
Via Business Wire
Texas A&M University Mays Business School and Humana Launch Sixth Annual Healthcare Analytics Case Competition
From Humana Inc.
Via Business Wire
The Top 5 Growth Stocks That Hedge Funds Are Buying Now
Hedge funds and mutual funds are starting to rotate back into growth stocks, replacing value stocks in the process. 
Via InvestorPlace
CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix
From Humana Inc.
Via Business Wire
Humana Board Declares Payment of Quarterly Dividend to Stockholders
From Humana Inc.
Via Business Wire
Humana to Expand Medicaid Services in Wisconsin with Acquisition of Inclusa, Inc.
From Humana Inc.
Via Business Wire
Humana Completes Divestiture of Majority Interest in Kindred at Home Hospice and Personal Care Divisions to CD&R
From Humana Inc.
Via Business Wire
What is Medicare Easy Pay & How Does it Works
Via Get News
The 7 Best Fidelity Funds for Retirees
These are the best Fidelity funds for retirees. FCNTX, FDIG, FXAIX, FSPHX, FSUTX, FSMO and FDVLX can make great buys in August. 
Via InvestorPlace
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.